Document is current
Any future updates will be listed below
-
Authors
Rydzewski, Nicholas R.
Peterson, Erik
Lang, Joshua M.
Yu, Menggang
Laura Chang, S.
Sjöström, Martin https://orcid.org/0000-0002-2629-9966
Bakhtiar, Hamza
Song, Gefei
Helzer, Kyle T. https://orcid.org/0000-0003-3853-5564
Bootsma, Matthew L.
Chen, William S.
Shrestha, Raunak M.
Zhang, Meng
Quigley, David A.
Aggarwal, Rahul
Small, Eric J.
Wahl, Daniel R.
Feng, Felix Y.
Zhao, Shuang G. https://orcid.org/0000-0002-9166-6507
- License Information
-
More Information
Article History
Received: 24 May 2021
Accepted: 23 August 2021
First Online: 21 September 2021
Competing interests
: J.M.L. holds equity in Salus Discovery LLC. R.A. has consulted for Janssen, Merck, AstraZeneca, Dendreon, Clovis, Pfizer, Amgen; RA has research funding from Amgen, Merck, Novartis, AstraZeneca, Xynomic, Zenith Epigenetics. E.J.S. has consulted for Janssen, Fortis Therapeutics, Harpoon Therapeutics, Teon Therapeutics. F.Y.F. has consulted for Astellas, Bayer, BlueEarth Diagnostics, Celgene, EMD Serono, Genentech, Janssen, Myovant, Ryovant, BMS, Exact Sciences, Varian, and serves on the scientific advisory board for Bluestar Genomics and Serimmune. S.L.C. is an employee of Exact Sciences. S.G.Z., S.L.C., and F.Y.F. have patent applications with Decipher Biosciences on molecular signatures in prostate cancer unrelated to this work. S.G.Z. and F.Y.F. have a patent application for a molecular signature in breast cancer unrelated to this work licensed to Exact Sciences. N.R.R., E.P., M.Y., M.S., H.B., G.F., K.T.H., M.L.B., W.S.C., R.M.S., M.Z., D.A.Q., and D.R.W. declare no competing interests.
